IL-27 promotes Treg cell expression of CD122 and fitness at homeostasis

Z Zachary R. Lanzar (Department of Pathobiology, University of Pennsylvania) D Daniel L. Aldridge (Department of Pathobiology, University of Pennsylvania) E Elisa Cruz-Morales (Department of Pathobiology, University of Pennsylvania) C Christian A. Howard (Department of Pathobiology, University of Pennsylvania) I Isabella O. Conway (Department of Pathobiology, University of Pennsylvania) Z Zhe Zhong (Translational Science and Therapeutics Division, Fred Hutch Cancer Center) J Julia N. Eberhard (Department of Pathobiology, University of Pennsylvania) J Joseph A. Pereira (Department of Immunology, Blavatnik Institute, Harvard Medical School) A Anthony T. Phan (Department of Pathobiology, University of Pennsylvania) A Aaron M. Ring M Melissa Parker (Incyte Research Institute, Incyte Corporation) C Chryssa Kanellopoulou (Incyte Research Institute, Incyte Corporation) B Booki Min (Department of Microbiology and Immunology, Northwestern University Feinberg School of Medicine) R Ross M. Kedl (Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, School of Medicine) D David A. Christian (Department of Pathobiology, University of Pennsylvania) C Christopher A. Hunter

Abstract

Regulatory T (Treg) cells express high levels of the IL-27R, and in the setting of infection and autoimmunity, the cytokine IL-27 promotes Treg cell activities that mitigate tissue pathology. However, IL-27 appears dispensable for Treg cell development and maintenance as lineage-specific depletion of the IL-27R on Treg cells does not impact these populations at steady state. In contrast, when mice were generated in which the Treg compartment comprised a mix of IL-27R-sufficient and -deficient Treg cells, those that lacked IL-27R were at a competitive disadvantage. Aging experiments illustrate that IL-27R-deficient Treg cells are preferentially eroded, and this defect was associated with reduced expression of CD122, the β chain of the IL-2/15R. Moreover, blockade of CD122 led to a similar loss of Treg cells, and in vitro and in vivo studies highlight that IL-27 promotes Treg cell expression of CD122 and improves responsiveness to IL-2/15. These datasets reveal that homeostatic IL-27 signals provide a competitive advantage that shapes the composition of the Treg cell pool by modulating responsiveness to growth factors.

Article Details

Volume / Issue Vol. 122, Issue 50
Published December 16, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (16)

Z

Zachary R. Lanzar

Department of Pathobiology, University of Pennsylvania

D

Daniel L. Aldridge

Department of Pathobiology, University of Pennsylvania

E

Elisa Cruz-Morales

Department of Pathobiology, University of Pennsylvania

C

Christian A. Howard

Department of Pathobiology, University of Pennsylvania

I

Isabella O. Conway

Department of Pathobiology, University of Pennsylvania

Z

Zhe Zhong

Translational Science and Therapeutics Division, Fred Hutch Cancer Center

J

Julia N. Eberhard

Department of Pathobiology, University of Pennsylvania

J

Joseph A. Pereira

Department of Immunology, Blavatnik Institute, Harvard Medical School

A

Anthony T. Phan

Department of Pathobiology, University of Pennsylvania

A

Aaron M. Ring

M

Melissa Parker

Incyte Research Institute, Incyte Corporation

C

Chryssa Kanellopoulou

Incyte Research Institute, Incyte Corporation

B

Booki Min

Department of Microbiology and Immunology, Northwestern University Feinberg School of Medicine

R

Ross M. Kedl

Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, School of Medicine

D

David A. Christian

Department of Pathobiology, University of Pennsylvania

C

Christopher A. Hunter